Targeting Treatment of Soft Tissue Sarcomas
Recent achievements in the development of new techniques and agents for the treatment of cancer in general as well as for soft tissue sarcomas are tremendous. Molecular biology research has changed the landscape considerably and an increasing number of subtypes of soft tissue sarcomas are related to...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic |
| Language: | English |
| Published: |
Boston, MA :
Springer US,
2004.
|
| Series: | Cancer Treatment and Research,
120 |
| Subjects: | |
| Online Access: | View fulltext via EzAccess |
Table of Contents:
- Targeted therapy: Ready for prime time?
- Volume-based radiotherapy targeting in soft tissue sarcoma
- Preoperative therapy for soft tissue sarcoma
- TNF-based isolated limb perfusion: A decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas
- Pitfalls in pathology of soft tissue sarcomas
- Molecular biology and cytogenetics of soft tissue sarcomas: Relevance for targeted therapies
- KIT and PDGF as targets
- Targeting mutant kinases in Gastrointestinal Stromal Tumors: A paradigm for molecular therapy of other sarcomas
- Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-? in liposarcomas
- Angiogenesis: a potential target for therapy of soft tissue sarcomas.